Chris Doering

Chris Doering

Company: Expression Therapeutics LLC

Job title: Chief Scientific Officer


Strategies to Improve the Durability of Gene Therapies for Hemophilia A 10:00 am

• Assessing clinical data to understand the durability of gene therapies for Hemophilia A • Comparing different delivery methods and the impact on durability • Understanding the optimal strategy to achieve maximum durabilityRead more

day: Day Two AM

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.